83 related articles for article (PubMed ID: 8638901)
21. Pharmacologic actions of the second-generation leukotriene B4 receptor antagonist LY293111: in vitro studies.
Jackson WT; Froelich LL; Boyd RJ; Schrementi JP; Saussy DL; Schultz RM; Sawyer JS; Sofia MJ; Herron DK; Goodson T; Snyder DW; Pechous PA; Spaethe SM; Roman CR; Fleisch JH
J Pharmacol Exp Ther; 1999 Jan; 288(1):286-94. PubMed ID: 9862783
[TBL] [Abstract][Full Text] [Related]
22. Pharmacological activity of the second generation leukotriene B4 receptor antagonist, SC-53228: effects on acute colonic inflammation and hepatic function in rodents.
Fretland DJ; Anglin CP; Widomski D; Baron DA; Maziasz T; Smith PF
Inflammation; 1995 Oct; 19(5):503-15. PubMed ID: 8543366
[TBL] [Abstract][Full Text] [Related]
23. Prostaglandins, leukotrienes, and other arachidonic acid metabolites in the pathogenesis of otitis media.
Jung TT
Laryngoscope; 1988 Sep; 98(9):980-93. PubMed ID: 2842558
[TBL] [Abstract][Full Text] [Related]
24. Ischemia-reperfusion injury in myocutaneous flaps: role of leukocytes and leukotrienes.
Kirschner RE; Fyfe BS; Hoffman LA; Chiao JJ; Davis JM; Fantini GA
Plast Reconstr Surg; 1997 May; 99(6):1485-93; discussion 1494-5. PubMed ID: 9145114
[TBL] [Abstract][Full Text] [Related]
25. Leukotriene B4 modulates in vivo expression of delayed-type hypersensitivity by a receptor-mediated mechanism: regulation by lipoxin A4.
Feng Z; Godfrey HP; Mandy S; Strudwick S; Lin KT; Heilman E; Wong PY
J Pharmacol Exp Ther; 1996 Aug; 278(2):950-6. PubMed ID: 8768752
[TBL] [Abstract][Full Text] [Related]
26. SB 209247, a high affinity LTB4 receptor antagonist demonstrating potent antiinflammatory activity.
Sarau HM; Foley JJ; Schmidt DB; Tzimas MN; Martin LD; Daines RA; Chambers PA; Kingsbury WD; Griswold DE
Adv Prostaglandin Thromboxane Leukot Res; 1995; 23():275-7. PubMed ID: 7732852
[No Abstract] [Full Text] [Related]
27. Effect of the leukotriene B4 receptor antagonist, SC-41930, on experimental allergic encephalomyelitis (EAE) in the guinea pig.
Fretland DJ; Widomski DL; Shone RL; Levin S; Gaginella TS
Agents Actions; 1991 Sep; 34(1-2):172-4. PubMed ID: 1665290
[TBL] [Abstract][Full Text] [Related]
28. The in vitro and in vivo pharmacologic activity of the potent and selective leukotriene B4 receptor antagonist CP-105696.
Showell HJ; Pettipher ER; Cheng JB; Breslow R; Conklyn MJ; Farrell CA; Hingorani GP; Salter ED; Hackman BC; Wimberly DJ
J Pharmacol Exp Ther; 1995 Apr; 273(1):176-84. PubMed ID: 7714764
[TBL] [Abstract][Full Text] [Related]
29. Identification on receptors for leukotriene B4 expressed on guinea-pig peritoneal eosinophils.
Sehmi R; Rossi AG; Kay AB; Cromwell O
Immunology; 1992 Sep; 77(1):129-35. PubMed ID: 1328044
[TBL] [Abstract][Full Text] [Related]
30. The leukotriene B4 receptor agonist/antagonist activities of SC-45694 in human neutrophils.
Tsai BS; Keith RH; Villani-Price D; Haack RA; Djuric SW
J Pharmacol Exp Ther; 1994 Mar; 268(3):1493-8. PubMed ID: 8138959
[TBL] [Abstract][Full Text] [Related]
31. Effects of leukotriene B4 receptor antagonist, LY293111Na, on antigen-induced bronchial hyperresponsiveness and leukocyte infiltration in sensitized guinea pigs.
Asanuma F; Kuwabara K; Arimura A; Furue Y; Fleisch JH; Hori Y
Inflamm Res; 2001 Mar; 50(3):136-41. PubMed ID: 11339501
[TBL] [Abstract][Full Text] [Related]
32. Middle ear mucosal inflammation: an in vivo model.
Chan KH; Swarts JD; Tan L
Laryngoscope; 1994 Aug; 104(8 Pt 1):970-80. PubMed ID: 8052083
[TBL] [Abstract][Full Text] [Related]
33. (E)-3-[6-[[(2,6-dichlorophenyl)thio]methyl]-3-(2-phenylethoxy)-2- pyridinyl]-2-propenoic acid: a high-affinity leukotriene B4 receptor antagonist with oral antiinflammatory activity.
Daines RA; Chambers PA; Foley JJ; Griswold DE; Kingsbury WD; Martin LD; Schmidt DB; Sham KK; Sarau HM
J Med Chem; 1996 Sep; 39(19):3837-41. PubMed ID: 8809171
[TBL] [Abstract][Full Text] [Related]
34. Incidence of otitis media in vitamin A-deficient guinea pigs.
Manning SC; Wright CG
Otolaryngol Head Neck Surg; 1992 Nov; 107(5):701-6. PubMed ID: 1437207
[TBL] [Abstract][Full Text] [Related]
35. ER-34122, a novel dual 5-lipoxygenase/cyclooxygenase inhibitor with potent anti-inflammatory activity in an arachidonic acid-induced ear inflammation model.
Horizoe T; Nagakura N; Chiba K; Shirota H; Shinoda M; Kobayashi N; Numata H; Okamoto Y; Kobayashi S
Inflamm Res; 1998 Oct; 47(10):375-83. PubMed ID: 9831321
[TBL] [Abstract][Full Text] [Related]
36. Inflammatory mediator changes in cotton-top tamarins (CTT) after SC-41930 anti-colitic therapy.
Clapp N; Henke M; Hansard R; Carson R; Walsh R; Widomski D; Anglin C; Fretland D
Agents Actions; 1993; 39 Spec No():C8-10. PubMed ID: 8273593
[TBL] [Abstract][Full Text] [Related]
37. Pharmacological studies of the new antiinflammatory agent 3-formylamino-7-methylsulfonylamino-6-phenoxy-4'-1-benzopyran-4-o ne. 2nd communication: effect on the arachidonic acid cascades.
Tanaka K; Makino S; Shimotori T; Aikawa Y; Inaba T; Yoshida C
Arzneimittelforschung; 1992 Jul; 42(7):945-50. PubMed ID: 1329779
[TBL] [Abstract][Full Text] [Related]
38. 3(S)-hydroxy-leukotriene B4 is a potent granulocyte chemotaxin in the guinea pig dermis.
Fretland D; Anglin C; Baron D; Widomski D; Chauhan K; Bhatt R; Falck J
Inflamm Res; 1995 Aug; 44 Suppl 2():S137-8. PubMed ID: 8548366
[No Abstract] [Full Text] [Related]
39. Mechanisms of leukotriene-induced contractions of guinea pig airways: leukotriene C4 has a potent direct action whereas leukotriene B4 acts indirectly.
Dahlén SE; Hedqvist P; Westlund P; Granström E; Hammarström S; Lindgren JA; Rådmark O
Acta Physiol Scand; 1983 Aug; 118(4):393-403. PubMed ID: 6314748
[TBL] [Abstract][Full Text] [Related]
40. [Studies on the characteristics of leukotriene B4 receptor with radio-ligand binding assay].
Zhao N; Zhu XY; Cheng GF
Yao Xue Xue Bao; 1996; 31(11):875-7. PubMed ID: 9863260
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
